Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 881

The company-funded animal test was performed to ascertain how neural development is affected by the pesticide chlorpyrifos, which is used on a wide variety of crops around the world, including some 20 EU countries. The test laboratory concluded that there was no such effect, even at high doses.

Academic researchers have examined raw data from a company-funded safety evaluation of the pesticide chlorpyrifos. They discovered an effect on the brain architecture of the exposed laboratory animals at all tested doses, which was not included in the reported conclusions. Karolinska Institutet in Sweden led this independent study, which is published in the scientific journal Environmental Health.

All pesticides must be evaluated in terms of their safety and potential risks for human health before they can officially be approved. Normally the companies that manufacture the products cover the cost of such evaluations and commission test laboratories to perform the necessary animal tests.

Assistant professor Axel Mie at Karolinska Institutet, Christina Rudén at Stockholm University and Philippe Grandjean at Harvard School of Public Health have examined a case in which independent research and company-funded tests deviated, at least in terms of the conclusions drawn in the industry-funded study.

Continue reading “Flaws in industry-funded pesticide evaluation” | >

MORGANTOWN — World-leading brain experts at West Virginia University’s Rockefeller Neuroscience Institute are celebrating the historic breakthrough Alzheimer patients around the global have been waiting for.

“For Alzheimer’s, there’s not that many treatments available despite hundreds of clinical trials over the past two decades and billions of dollars spent,” said Dr. Ali Rezai, a neurosurgeon at WVU who led the team of investigators that successfully performed a phase II trial using focused ultrasound to treat a patient with early stage Alzheimer’s.

The WVU team tested the innovative treatment in collaboration with INSIGHTEC, an Israeli medical technology company. Earlier this year, INSIGHTEC was approved by the U.S. Food and Drug Administration to begin a phase II clinical trial of the procedure and selected the WVU Rockefeller Neuroscience Institute as the first site in the United States for the trial.

Read more

Samsung TVs are already some of the most popular options for high-end home theater systems, and the company is now using its television-making prowess to help people with disabilities live more normal lives. A new project by a Samsung team in Switzerland could yield the first smart TV that can be controlled with thoughts.

As CNET reports, Samsung has partnered with Swiss scientists to bring the system to life. Called ‘Project Pontis,’ the ultimate goal is to build a brain/software interface that will allow individuals with movement disabilities to control television features like channel switching and volume control with their brains rather than their bodies.

Read more

Motivation is such an intangible aspect of the human spirit that we often forget it has very real, neurochemical origins. We admire it in others and strive for it in ourselves (see: every Nike ad ever made), and now we are getting closer to potentially inducing that motivational feeling with drugs.

John Salamone, Ph.D., a professor at the University of Connecticut with a background in neural and behavioral pharmacology, has been working with the drug company Chronos Therapeutics to develop a drug that can restore motivation in people who have lost it — whether that’s due to the symptoms of depression, struggle with disease, or otherwise. He unveiled his early results on rats this week in a presentation at the Society For Neuroscience’s conference in San Diego, where he tells Inverse his board was bustling with activity:

“Basically we stood there for four hours and were busy the entire time,” says Salamone. The reception was overwhelmingly positive, he adds. “We didn’t have anyone say ‘This is crazy! This will never work!’”.

Read more

I think aspects of our Universe are conscious. Dark matter or the æther perhaps. Stagnancy is death so change inherently means something is making decisions.

A new scientific concept has recently come to light, which scientists are calling “panpsychism.” Panpsychism says that the universe could be capable of consciousness, which could change everything.

For quite some time, scientists have been working to understand the universe, where it came from, and why we are here. However, they have often come up short until now. The scientist responsible for such a notion is Gregory Matloff, and his ideas are shocking, to say the least.

Continue reading “Scientists Now Believe That The Universe Itself Is Conscious” | >

SpiNNaker was built under the leadership of Professor Steve Furber at The University of Manchester, a principal designer of two products that earned the Queen’s Award for Technology —the ARM 32-bit RISC microprocessor, and the BBC Microcomputer.

“The ultimate objective for the project has always been a million cores in a single computer for real time brain modelling applications, and we have now achieved it, which is fantastic.” — Professor Steve Furber, The University of Manchester

Inspired by the human brain, the SpiNNaker is capable of sending billions of small amounts of information simultaneously. The SpiNNaker has a staggering 1 million processors that are able to perform over 200 million actions per second.

Read more